HLS- sbir phase i: targeted platelet-capsule hybrids for on demand treatment in hemophilia
Ended Project Grant Awarded
- Award ID
- R43HL142404
- Recipient
-
Split Rock Therapeutics LLC UEI MNEMHLAFYFB6
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $223,898
Award facts
- Assistance listing
- 93.839 Blood Diseases and Resources Research
- Completion date
- Place of performance
- Tucker, GA 30084, USA
Award details come from USAspending.gov.
Quick answers
Who received award R43HL142404?
R43HL142404 was awarded to Split Rock Therapeutics LLC by National Heart Lung and Blood Institute (National Institutes of Health) on September 25, 2019.
How much is award R43HL142404 worth?
$223,898 has been obligated on R43HL142404.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award